Overview

This trial is active, not recruiting.

Condition hemangioma
Treatment observation
Sponsor Zhujiang Hospital
Start date December 2014
End date February 2015
Trial size 39 participants
Trial identifier NCT02351245, IH201412

Summary

Lip hemangiomas are at higher risk than those located in other sites. However, studies about clinical characteristics of lip hemangiomas have not been enough. The investigators want to conduct a prospective study on the clinical features of lip hemangiomas.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Arm
observation

Primary Outcomes

Measure
appearance time, location, size, complication of lip hemangiomas
time frame: up to 2 months

Secondary Outcomes

Measure
demographic information
time frame: up to 1 month
maternal specific events
time frame: up to 1 month

Eligibility Criteria

Male or female participants up to 2 years old.

Inclusion Criteria: - Only lip hemangiomas visiting between June 1, 2010 and October 1, 2014 were included in this study, which was defined as any infantile hemangioma covering any part of vermilion. Exclusion Criteria: - Perioral hemangiomas which did not involve vermilion were excluded.

Additional Information

Official title Clinical Characteristics and Complications of Infantile Hemangiomas Located in Lips
Description Hemangiomas involving lip are of special concern, since they occur in a prominent location on the face and can distort lip anatomy and lead to disfunction. Infantile hemangiomas in lip had significantly higher incidence than the others. It is often difficult to decide which patient with an lip hemangioma is at higher risk. The investigators are interested in conducting a study on the clinical features of lip hemangiomas. The investigators are collecting medical records and photos of lip hemangiomas, including demographic information, maternal process, birth, location, size and complication. Based on the data, sum up the main points of clinical characteristics and complication.
Trial information was received from ClinicalTrials.gov and was last updated in January 2015.
Information provided to ClinicalTrials.gov by Zhujiang Hospital.